关注
Björn Wettermark
Björn Wettermark
在 farmaci.uu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months
B Wettermark, N Hammar, C MichaelFored, A Leimanis, ...
Pharmacoepidemiology and drug safety 16 (7), 726-735, 2007
18532007
The Nordic countries as a cohort for pharmacoepidemiological research
K Furu, B Wettermark, M Andersen, JE Martikainen, AB Almarsdottir, ...
Basic & clinical pharmacology & toxicology 106 (2), 86-94, 2010
6322010
The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden
R Zarrinkoub, B Wettermark, P Wändell, M Mejhert, R Szulkin, ...
European journal of heart failure 15 (9), 995-1002, 2013
4222013
The ‘wise list’–a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm
LL Gustafsson, B Wettermark, B Godman, E Andersén‐Karlsson, ...
Basic & clinical pharmacology & toxicology 108 (4), 224-233, 2011
2922011
Drug utilization 90%–a simple method for assessing the quality of drug prescribing
U Bergman, C Popa, Y Tomson, B Wettermark, TR Einarson, H Åberg, ...
European journal of clinical pharmacology 54, 113-118, 1998
2911998
The first decade with the Swedish prescribed drug register–a systematic review of the output in the scientific literature
SM Wallerstedt, B Wettermark, M Hoffmann
Basic & clinical pharmacology & toxicology 119 (5), 464-469, 2016
2282016
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review
B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ...
Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013
2112013
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Expert review of pharmacoeconomics & outcomes research 10 (6), 707-722, 2010
2082010
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1862009
Association between proton pump inhibitor use and risk of progression of chronic kidney disease
DCF Klatte, A Gasparini, H Xu, P de Deco, M Trevisan, ALV Johansson, ...
Gastroenterology 153 (3), 702-710, 2017
1772017
Drug utilization research: methods and applications
M Elseviers, B Wettermark, AB Almarsdóttir, M Andersen, R Benkö, ...
John Wiley & Sons, 2016
1682016
High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden–a challenge for public health
AC Carlsson, P Wändell, U Ösby, R Zarrinkoub, B Wettermark, ...
BMC public health 13, 1-8, 2013
1662013
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
B Godman, B Wettermark, M Van Woerkom, J Fraeyman, ...
Frontiers in pharmacology 5, 106, 2014
1622014
Prevalence and recognition of chronic kidney disease in Stockholm healthcare
A Gasparini, M Evans, J Coresh, ME Grams, O Norin, AR Qureshi, ...
Nephrology Dialysis Transplantation, gfw354, 2016
1602016
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ...
Frontiers in Public Health 6, 328, 2018
1592018
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
T Forslund, B Wettermark, P Hjemdahl
European journal of clinical pharmacology 72, 329-338, 2016
1552016
Policies to enhance prescribing efficiency in Europe: findings and future implications
B Godman, W Shrank, M Andersen, C Berg, I Bishop, T Burkhardt, ...
Frontiers in pharmacology 1, 141, 2011
1512011
Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden
D Loikas, B Wettermark, M von Euler, U Bergman, K Schenck-Gustafsson
BMJ open 3 (5), e002378, 2013
1502013
Validation of asthma and eczema in population‐based Swedish drug and patient registers
AK Örtqvist, C Lundholm, B Wettermark, JF Ludvigsson, W Ye, C Almqvist
Pharmacoepidemiology and drug safety 22 (8), 850-860, 2013
1352013
Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011
P Wändell, AC Carlsson, B Wettermark, G Lord, T Cars, G Ljunggren
Family practice 30 (5), 506-513, 2013
1322013
系统目前无法执行此操作,请稍后再试。
文章 1–20